抗血管生成药物在非小细胞肺癌中的应用及研究进展(6)
[26]Gu AQ,Han BH,Zhang XY,et al.Randomized study of thalidomide combined with vinorelbine and cisplatin chemotherapy for the treatment of advanced non-small cell lung cancer[J].Chinese Journal of Oncology,2009,31(4):298-301.
[27]Wang GH,Wu PF,Zhang LH,et al.Use of erlotinib and thalidomide in advanced NSCLC patients with acquired resistance to erlotinib: A pilot study[J].Pathol Res Pract,2018,214(2):263-267.
[28]Bao Y,Peng F,Zhou QC,et al.Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer[J].Radiother Oncol,2015,114(2):161-166.
[29]Sun XJ,Deng QH,Yu XM,et al.A phase II study of Endostatin in combination with paclitaxel, carboplatin, and radiotherapy in patients with unresectable locally advanced non-small cell lung cancer[J].BMC Cancer,2016,16(1):266.
收稿日期:2018-12-18;修回日期:2019-1-29
編辑/杨倩
作者简介:杨珑静(1991.1-),女,四川成都人,硕士研究生,住院医师,主要从事肺癌的临床诊治及研究
通讯作者:张献全(1965.6-),男,重庆人,教授,博士,重庆市医学会肿瘤专委会副主任委员、重庆市抗癌协会肿瘤专委会副主任委员,主要从事肿瘤耐药机制、信号转导和分子靶向治疗方向的研究, 百拇医药(杨珑静 马洪波 张献全)
[27]Wang GH,Wu PF,Zhang LH,et al.Use of erlotinib and thalidomide in advanced NSCLC patients with acquired resistance to erlotinib: A pilot study[J].Pathol Res Pract,2018,214(2):263-267.
[28]Bao Y,Peng F,Zhou QC,et al.Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer[J].Radiother Oncol,2015,114(2):161-166.
[29]Sun XJ,Deng QH,Yu XM,et al.A phase II study of Endostatin in combination with paclitaxel, carboplatin, and radiotherapy in patients with unresectable locally advanced non-small cell lung cancer[J].BMC Cancer,2016,16(1):266.
收稿日期:2018-12-18;修回日期:2019-1-29
編辑/杨倩
作者简介:杨珑静(1991.1-),女,四川成都人,硕士研究生,住院医师,主要从事肺癌的临床诊治及研究
通讯作者:张献全(1965.6-),男,重庆人,教授,博士,重庆市医学会肿瘤专委会副主任委员、重庆市抗癌协会肿瘤专委会副主任委员,主要从事肿瘤耐药机制、信号转导和分子靶向治疗方向的研究, 百拇医药(杨珑静 马洪波 张献全)